Trade ORMP anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Oramed Pharmaceuticals Inc. (ORMP) is trading at US$5.06, down 0.78% today as of Aug 28, 12:21 EDT. The company has a market capitalisation of US$200.08M. Over the past 52 weeks, ORMP has traded between US$2.09 and US$5.47. On Syfe you can trade ORMP with $0 commission and add it to your watchlist.
| Previous close | US$5.10 |
|---|---|
| Market cap | US$200.08M |
| P/E ratio | 2.19 |
| 52-week range | US$2.09 – US$5.47 |
| Volume | 275.95K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
Year: 2004
Lifeward Enters Securities Purchase Agreement Under Oramed Financing Framework
Jul 7, 9:22 PM · MT Newswires
Lifeward Closes Oramed Partnership, Acquires Oratech Pharma
Mar 25, 10:04 PM · MT Newswires
Lifeward Shareholders Approve Share Issuance for Oramed Partnership
Mar 13, 4:14 PM · MT Newswires
Oramed Pharmaceuticals Inc. (ORMP) stock is trading at US$5.06, -0.78% from the previous close of US$5.10.
The market cap for Oramed Pharmaceuticals Inc. (ORMP) stock is approximately US$200.08M.
The price-to-earnings ratio for Oramed Pharmaceuticals Inc. (ORMP) is 2.19, based on the latest reported earnings.
The 52-week high for Oramed Pharmaceuticals Inc. (ORMP) stock is US$5.47.
The 52-week low for Oramed Pharmaceuticals Inc. (ORMP) stock is US$2.09.
Oramed Pharmaceuticals Inc. (ORMP) does not currently pay a dividend.
Stay on top of ORMP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
